| 前收盘价格 | 23.66 |
| 收盘价格 | 23.55 |
| 成交量 | 587,496 |
| 平均成交量 (3个月) | 721,455 |
| 市值 | 1,186,618,240 |
| 预期市盈率 (P/E Forward) | 94.34 |
| 价格/销量 (P/S) | 3.33 |
| 股市价格/股市净资产 (P/B) | 4.30 |
| 52周波幅 |
| 营业毛利率 | 17.92% |
| 营业利益率 (TTM) | -9.46% |
| 稀释每股收益 (EPS TTM) | 1.12 |
| 季度收入增长率 (YOY) | 17.50% |
| 总债务/股东权益 (D/E MRQ) | 7.98% |
| 流动比率 (MRQ) | 4.11 |
| 营业现金流 (OCF TTM) | 26.78 M |
| 杠杆自由现金流 (LFCF TTM) | 29.89 M |
| 资产报酬率 (ROA TTM) | -5.20% |
| 股东权益报酬率 (ROE TTM) | 19.54% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Diagnostics & Research (US) | 混合的 | 看涨 |
| Diagnostics & Research (全球的) | 混合的 | 看涨 | |
| 股票 | CareDx, Inc. | 看涨 | 看跌 |
AIStockmoo 评分
| 分析师共识 | 2.0 |
| 内部交易活动 | 1.5 |
| 价格波动 | -4.5 |
| 技术平均移动指标 | 2.5 |
| 技术振荡指标 | 4.0 |
| 平均 | 1.10 |
|
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically it generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services. |
|
| 部门 | Healthcare |
| 行业 | Diagnostics & Research |
| 投资方式 | Small Core |
| 内部持股比例 | 3.22% |
| 机构持股比例 | 99.39% |
该时间范围内无数据。
| 名称 | 平均购买 ($) | 平均卖出 ($) | 总净额 | 总净值 ($) |
|---|---|---|---|---|
| BICKERSTAFF GEORGE | 22.97 | - | 9,795 | 224,991 |
| COHEN FRED E | 22.97 | - | 9,795 | 224,991 |
| COURNOYER CHRISTINE | 22.97 | - | 9,795 | 224,991 |
| GOLDBERG MICHAEL | 22.97 | - | 9,795 | 224,991 |
| GUNASEKARAN SURESH | 22.97 | - | 9,795 | 224,991 |
| HANNA JOHN WALTER JR | - | 23.87 | -39,681 | -946,279 |
| RIGGSBEE RICHARD BRYAN | 22.97 | - | 9,795 | 224,991 |
| VALANTINE HANNAH | 22.97 | 24.08 | -2,308 | -66,449 |
| 累积净数量 | 16,781 | |||
| 累积净值 ($) | 337,218 | |||
| 累积平均购买 ($) | 22.97 | |||
| 累积平均卖出 ($) | 23.94 | |||
| 内部人员交易波幅 ($) | ||||
| 名称 | 持有人 | 日期 | 类型 | 数量 | 价格 | 价值 ($) |
|---|---|---|---|---|---|---|
| VALANTINE HANNAH | 董事 | 15 Jun 2026 | 自动卖出 (-) | 12,103 | 24.08 | 291,440 |
| HANNA JOHN WALTER JR | 职员 | 15 Jun 2026 | 自动卖出 (-) | 17,683 | 24.08 | 425,807 |
| GOLDBERG MICHAEL | 董事 | 12 Jun 2026 | 获得 (+) | 9,795 | 22.97 | 224,991 |
| BICKERSTAFF GEORGE | 董事 | 12 Jun 2026 | 获得 (+) | 9,795 | 22.97 | 224,991 |
| GUNASEKARAN SURESH | 董事 | 12 Jun 2026 | 获得 (+) | 9,795 | 22.97 | 224,991 |
| COHEN FRED E | 董事 | 12 Jun 2026 | 获得 (+) | 9,795 | 22.97 | 224,991 |
| RIGGSBEE RICHARD BRYAN | 董事 | 12 Jun 2026 | 获得 (+) | 9,795 | 22.97 | 224,991 |
| COURNOYER CHRISTINE | 董事 | 12 Jun 2026 | 获得 (+) | 9,795 | 22.97 | 224,991 |
| VALANTINE HANNAH | 董事 | 12 Jun 2026 | 获得 (+) | 9,795 | 22.97 | 224,991 |
| HANNA JOHN WALTER JR | 职员 | 11 Jun 2026 | 自动卖出 (-) | 21,998 | 23.66 | 520,473 |
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合